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CARDIOVASCULAR MEDICINE
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and increased arterial stiffness in children with a history of
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Objectives: To test the hypothesis that low grade inflammation persists after the acute phase and affects
arterial stiffness in children with a history of Kawasaki disease.
Design and patients: A cohort of 106 children was studied, which comprised 43 patients with Kawasaki
disease with coronary aneurysms (group I), 28 patients with Kawasaki disease with normal coronary
arteries (group II), and 35 healthy age matched children (group III). Their systemic blood pressure, fasting
cholesterol concentrations, serum high sensitivity C reactive protein (hs-CRP) concentrations, and carotid
artery stiffness index were compared. Significant determinants of serum hs-CRP concentration and carotid
artery stiffness were identified and the relation between hs-CRP concentration and arterial stiffness was
investigated.
Setting: Tertiary paediatric cardiac centre.
Results: Serum hs-CRP concentration of group I patients (median 0.39 mg/l, interquartile range 0.28–
0.65 mg/l) was significantly greater than that of group II (median 0.24 mg/l, interquartile range 0.17–
0.29 mg/l, p , 0.001) and of group III patients (median 0.25 mg/l, interquartile range 0.18–0.40 mg/l,
p , 0.01). Likewise, carotid artery stiffness index of group I patients (mean (SD) 5.07 (1.11)) was
significantly greater than that of group II (4.27 (0.83), p = 0.002), and of group III patients (4.24 (0.86),
p = 0.001). For the entire cohort, the carotid artery stiffness index correlated positively with log serum hs-
CRP concentration (r = 0.24, p = 0.013). In multiple linear regression analysis, age (standardised
b = 0.22, p = 0.02), systolic blood pressure (standardised b = 0.28, p = 0.01), log serum hs-CRP
concentration (standardised b = 0.21, p = 0.017), and patient grouping (standardised b = 20.36,
p , 0.001) were all independently associated with the carotid artery stiffness index.
Conclusions: These findings support the possibility of ongoing low grade inflammation late after the acute
phase of Kawasaki disease in patients with coronary aneurysms. Furthermore, this low grade
inflammation may have a role in increasing systemic arterial stiffness.
K
awasaki disease, a systemic vasculitis with predilection
for Asian children, is the most common acquired heart
disease in children in developed countries.1 The
sequelae of inflammation involving coronary and other
medium sized muscular arteries in the acute phase of
Kawasaki disease have been well documented.2–4 In the
absence of significant coronary artery complications, long
term morbidity has generally been regarded as minimal.2
Nonetheless, fatal cases of Kawasaki disease that occurred
years after apparent resolution of vascular inflammation and
in the absence of early detectable coronary artery abnorm-
alities have recently been reported.5 Histological examination
showed extensive fibrointimal thickening and infiltration of
lymphocytes and plasma cells in the coronary arterial walls.5
These findings suggest that chronic low grade arterial
inflammation is possible even years after resolution of the
acute phase of Kawasaki disease.
Recently, there has been a surge of studies of adults
showing a direct association between slightly increased
baseline high sensitivity C reactive protein (hs-CRP) serum
concentrations and the risk of developing cardiovascular
disease.6–8 While CRP has traditionally been regarded as
merely a marker of inflammation, recent evidence suggests
that it may contribute directly to a proinflammatory state and
pathogenesis of vascular damage.9–12 Whether serum CRP
concentration remains slightly increased late after Kawasaki
disease, as a reflection of chronic low grade inflammation,
has not been determined, however.
Evidence of systemic arterial dysfunction late after
Kawasaki disease, on the other hand, is accumulating.
Dhillon and colleagues13 have shown abnormalities of
brachial artery endothelial function years after resolution of
acute Kawasaki disease, even in patients without detectable
early coronary artery involvement. Our group has further
reported that the stiffness of peripheral conduit arteries is
increased in patients who did not receive immunoglobulin
within 10 days of disease onset.14 Recently, increased carotid
artery stiffness has also been shown in patients who had
associated coronary aneurysms.15
Given the preliminary evidence of late systemic artery
dysfunction in Kawasaki disease and a possible link between
chronic low grade inflammation and the risk of developing
cardiovascular disease, we hypothesised that low grade
inflammation persists for years after resolution of the acute
phase of Kawasaki disease and that this inflammation may
be associated with abnormal systemic artery function. To test
this hypothesis, we compared the serum hs-CRP concentra-
tions in children and adolescents with a history of Kawasaki
disease with those in age matched healthy children and
further determined the relation between serum hs-CRP
concentration and carotid artery stiffness.
PATIENTS AND METHODS
Patients and design
Patients with a history of Kawasaki disease were recruited
from the paediatric cardiac clinic of Grantham Hospital. The
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following data were retrieved from their clinical records: age
and symptoms at presentation, sex, use of intravenous
immunoglobulin during the acute phase, coronary artery
complications, current medications, and duration from onset
of disease to the time of the study. Patients who had
Kawasaki disease within 12 months of the study were
excluded to minimise a potential confounding influence
relating to subacute inflammation.16 Healthy children
matched to the mean age of patients with Kawasaki disease
were recruited as controls. The institutional ethics committee
approved the study and parents of all subjects gave written,
informed consent.
The participants were categorised into three groups for
comparisons. Group I comprised patients with Kawasaki
disease and a history of documented coronary artery
aneurysms; group II comprised patients without a history
of coronary artery aneurysms; and group III comprised
healthy age matched control patients. Coronary artery
aneurysms were documented by serial two dimensional
echocardiographic studies that were performed at the second
week of illness and then at one, three, six, and 12 months.
Patients with persistent aneurysms were assessed by echo-
cardiography every six to 12 months thereafter.
All participants attended the study after an overnight fast.
Body weight and height were measured and body mass index
was calculated accordingly. All children rested for at least 15
minutes before blood pressure and cardiovascular assess-
ments. Blood pressure in the right arm was measured twice
with an automated oscillometric device (Dinamap, Critikon,
Tampa, Florida, USA) and the two readings were averaged.
Carotid artery stiffness was assessed as described below.
Venous blood was then withdrawn from all participants for
measurement of fasting cholesterol and hs-CRP concentrations.
Measurement of carotid artery stiffness
Carotid artery stiffness was assessed by calculating the
stiffness index.17 A 7215 MHz linear array transducer
interfaced to a Sonos 5500 ultrasound machine (Hewlett
Packard, Andover, Massachusetts, USA) was used to image
the right carotid artery at about 1 cm proximal to the carotid
bifurcation. The diameter was measured between the intima
of the near and far walls, perpendicular to the course of the
artery. The maximum diameter at systole and the minimum
diameter at end diastole, as defined by the R wave of the
ECG, were measured. Three measurements each of systolic
and diastolic diameters were averaged for calculation of the
stiffness index according to the formula ln (SBP/DBP)/(dD/
D),17 where SBP is systolic blood pressure, DBP is diastolic
blood pressure, dD is the difference between systolic and
diastolic diameters, and D is the mean diameter. The
intraobserver variability for measurement of systolic and
diastolic diameters, as determined from the mean and SD of
differences in two consecutive results from 20 studies, were
20.01 (0.18) mm and 0.00 (0.18) mm, respectively.
Measurement of cholesterol and hs-CRP
concentrations
Plasma total cholesterol concentration was determined
enzymatically on a Hitachi 912 analyser (Roche Diagnostics
GmbH, Mannheim, Germany). High density lipoprotein
(HDL) cholesterol was measured by a homogeneous method
with polyethylene glycol modified enzymes and sulfated a
cyclodextrin. Low density lipoprotein (LDL) cholesterol was
calculated by the Friedewald equation. The CRP was
measured with a highly sensitive assay, which is a particle
enhanced immunoturbidimetric assay consisting of an anti-
CRP monoclonal antibody coupled to latex microparticles
(Roche Diagnostics). The assay is standardised against a
CRM 470 reference preparation for proteins in human serum
and has a functional sensitivity of 0.1 mg/l.
Statistical analysis
Data are presented as mean (SD) and median (range) as
appropriate. To compare the differences between groups, one
way analysis of variance and post hoc Tukey test were used
for parametric variables, Kruskal-Wallis test with post hoc
comparison by Dunn’s multiple comparison test for non-
parametric variables, and x2 test for categorical variables. For
comparison of two groups of non-parametric variables, the
Mann-Whitney U test was used. As CRP concentrations had a
skewed distribution, logarithmically transformed CRP con-
centrations were used in linear regression analyses.
Furthermore, CRP concentrations in each of the groups were
expressed as median and interquartile range. Stepwise
multiple linear regression analyses of the entire cohort were
used to identify significant determinants of serum CRP
concentration and carotid artery stiffness. The groups of
patients were entered as dummy variables (1 for group I, 2 for
group II, and 3 for group III). Within the groups with
Kawasaki disease (groups I and II), Spearman’s correlation
analysis was used to assess for a possible relation between
CRP concentrations (logarithmically transformed) and the
time since the acute illness. Significance was defined as a
p , 0.05. All statistical analyses were done with SPSS
version 10.0 (SPSS Inc, Chicago, Illinois, USA).
RESULTS
Participants
A total of 106 participants were studied. Group I comprised
43 patients, of whom 24 had persistent small coronary
aneurysms, two had giant aneurysms, and 17 had regressed
aneurysms. None had symptoms of myocardial ischaemia
and none required coronary artery interventions. Group II
comprised 28 patients with Kawasaki disease but without
documented coronary artery lesions. Of the total of 71
patients with Kawasaki disease, all but five had received
intravenous immunoglobulin during the acute phase of
illness and 32 were continuing to take long term oral low
dose aspirin. The patients were studied at a median time
interval of 7.2 years (range 1.0–16.6 years) from onset of
disease. Group III comprised 35 healthy control participants.
Table 1 summarises the demographic, haemodynamic, and
lipid profiles of all three groups. The three groups did not
differ significantly with regard to age at presentation, age at
the time of study, sex distribution, body mass index, systemic
blood pressure, and total cholesterol concentration. However,
in agreement with previous reports,18 HDL cholesterol was
significantly lower in group I patients.
Serum hs-CRP concentrations
The serum hs-CRP concentrations had a positively skewed
distribution. Only one of the patients had an hs-CRP
concentration of less than the detectable limit, which was
assigned a value of 0.05 mg/l.
The hs-CRP concentration of group I patients (median
0.39 mg/l, interquartile range 0.28–0.65 mg/l) was signifi-
cantly greater than that of group II (median 0.24, inter-
quartile range 0.17–0.29 mg/l, p , 0.001) and of group III
patients (median 0.25 mg/l, interquartile range 0.18–
0.40 mg/l, p , 0.01) (fig 1). There was, however, no
significant difference in hs-CRP concentrations between
group II and group III (p . 0.05). Within group I, patients
with persistent coronary artery aneurysms had hs-CRP
concentrations (median 0.36, interquartile range 0.24–0.53)
similar to those with regressed aneurysms (median 0.36,
interquartile range 0.24–0.69, p = 0.65).
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Multiple linear regression of the entire cohort of 106
patients was performed to identify significant determinants
of serum hs-CRP concentrations. The following dependent
variables were tested: age, sex, body mass index, SBP, DBP,
HDL and LDL cholesterol concentrations, and patient group-
ing. Significant determinants were body mass index (stan-
dardised b = 0.42, p , 0.001) and patient grouping
(standardised b = 20.19, p = 0.035). Thus, patients with
coronary artery aneurysms had significantly higher hs-CRP
concentrations even after adjustments of age, sex, body mass
index, SBP, and HDL cholesterol, all of which have been
found to correlate with baseline hs-CRP concentrations in
healthy children.19 There was, however, no correlation
between hs-CRP concentrations and the time since the acute
illness among patients (p = 0.60).
Carotid artery stiffness
The mean (SD) carotid artery stiffness index of group I (5.07
(1.11)) was significantly greater than that of group II (4.27
(0.83), p = 0.002) and of group III patients (4.24 (0.86),
p = 0.001). Importantly, there was a significant positive
correlation between carotid artery stiffness index and log
serum hs-CRP concentration (r = 0.24, p = 0.013) (fig 2).
Multiple linear regression of the entire cohort was similarly
performed to identify significant determinants of carotid
artery stiffness index. Dependent variables that were entered
into the multivariate model were age, sex, body mass index,
SBP, DBP, HDL, and LDL cholesterol concentrations, serum
hs-CRP concentrations, and patient grouping. Significant
determinants were age (standardised b = 0.22, p = 0.02),
SBP (standardised b = 0.28, p = 0.01), serum hs-CRP
concentrations (standardised b = 0.21, p = 0.017), and
patient grouping (standardised b = 20.36, p , 0.001).
DISCUSSION
This study showed that serum hs-CRP concentrations are
significantly increased in children and adolescents with a
history of Kawasaki disease complicated by coronary aneur-
ysm formation. Importantly, there is a positive relation
between CRP concentration and carotid artery stiffness. Our
findings provide the first evidence that chronic low grade
inflammation may continue after the acute phase of
Kawasaki disease and perhaps have a role in alteration of
arterial function.
While a significant increase of CRP concentration is
characteristic during the acute phase of Kawasaki disease,
the baseline hs-CRP concentration and its significance in the
late phase of the disease have not been determined. Recent
studies of adults have shown a direct association between
slightly increased baseline hs-CRP concentrations and the
risk of developing cardiovascular disease.6–8 Furthermore,
increased concentrations of hs-CRP have been found to
predict recurrent ischaemia, myocardial ischaemia, and
sudden death among adult patients with multiple risk factors
for coronary artery disease.20 21 In children with Kawasaki
disease, at sites of persistent and even regressed coronary
artery aneurysms, structural alterations with intimal thick-
ening and smooth muscle cell proliferation and functional
alterations as characterised by arterial stiffness and endothe-
lial dysfunction are well documented.3 4 Furthermore, reports
Table 1 Demographic, haemodynamic, and lipid profiles of the three groups
Group I (n = 43) Group II (n = 28) Group III (n = 35) p Value
Age at study (years) 10.2 (4.1) 9.7 (3.2) 10.3 (3.6) 0.72
Age at diagnosis of Kawasaki disease (years) 1.3 (0.2–7.3) 1.8 (0.2–10.7) NA 0.27
Interval from diagnosis to time of study (years) 7.8 (1–16.6) 6.9 (1.1–13.2) NA 0.11
Sex (male:female) 28:15 19:9 25:10 0.84
Body mass index (kg/m2) 17.5 (2.8) 16.9 (2.8) 17.3 (3.3) 0.14
Systolic blood pressure (mm Hg) 120 (14) 107 (8) 109 (10) 0.53
Diastolic blood pressure (mm Hg) 58 (9) 58 (5) 57 (7) 0.61
Total cholesterol (mmol/l) 4.36 (0.81) 4.43 (0.84) 4.21 (0.78) 0.54
HDL cholesterol (mmol/l) 1.31 (0.25) 1.46 (0.28) 1.46 (0.33) 0.035*
LDL cholesterol (mmol/l) 2.65 (0.69) 2.64 (0.75) 2.34 (0.71) 0.13
Data are mean (SD) or mean (range).
*Significant.
HDL, high density lipoprotein; LDL, low density lipoprotein; NA, not applicable.
Figure 1 Distribution of serum C reactive protein (CRP) concentrations
(on a log scale) in the three groups of patients. The horizontal lines
represent the medians in each of the groups.
Figure 2 Scatter plot showing a positive correlation between serum
CRP concentration (logarithmically transformed) and carotid artery
stiffness index.
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are accumulating of coronary artery sequelae in patients with
early Kawasaki disease leading to ischaemic heart disease in
young adults.22 23 Our findings of increased baseline hs-CRP
concentrations in children and adolescents with coronary
artery sequelae late after the acute phase of Kawasaki disease
may therefore have important implications.
Increased hs-CRP concentrations in the presence of
associated coronary aneurysms, whether persistent or
regressed, is probably a reflection of continuing low grade
vasculitis. This corroborates with the previously reported
histological findings of infiltration of lymphocytes and
plasma cells in the arterial walls of patients who died years
after apparent resolution of the acute vascular inflammation.5
As Takahashi24 suggested, while intravenous immunoglobu-
lin has been effective in extinguishing the fire during the
acute stage of Kawasaki disease, it might have failed to snuff
out the smouldering vasculitis in the later stage of the
disease. Our findings support this proposition and further
suggest that this smouldering vasculitis may perhaps play a
part in altering arterial function.
Increased carotid stiffness in the absence of major
alteration of the lipid profile has recently been described by
Noto and colleagues15 in a group of 20 adolescents with
Kawasaki disease and coronary artery lesions. Patients
without coronary artery complications were, however, not
included in their study. Our findings corroborate with theirs
and further show that patients without coronary artery
lesions have normal carotid artery stiffness. The underlying
mechanisms accounting for the increase in carotid artery
stiffness remain speculative. Nonetheless, the fact that
patient status is one of the significant determinants of
stiffness suggests that diffuse vasculitis, involving both
coronary and non-coronary arteries, changes the arterial wall
structure and hence its elastic modulus may be one of the
possible mechanisms. However, there is no documented
evidence of a histological difference between sick and healthy
people.
On the other hand, an additional novel finding of the
present study is the significant positive correlation between
serum hs-CRP concentrations and arterial stiffness. In adults,
increased hs-CRP concentrations have been found to be
associated with endothelial dysfunction in patients with
coronary artery disease.10 In vitro studies have further shown
that CRP induces adhesion molecule expression in human
endothelial cells in the presence of serum.25 In the only
available study among healthy children of the impact of
increased hs-CRP concentrations on arterial changes,26
increased hs-CRP concentrations were found to be associated
with increased intima–media thickness and likewise
endothelial dysfunction. Indeed, increased intima–media
thickness measured by carotid ultrasonography has been
found in patients with a history of Kawasaki disease and
coronary aneurysms.15 Thus, our findings together with those
of the other groups may tempt one to speculate that increased
serum hs-CRP concentrations may predispose to structural
and functional changes of arteries in these patients.
Nonetheless, in children and adolescents who do not have
much of an atherosclerotic burden, whether hs-CRP is indeed
a risk factor or a risk marker requires further clarification.27
A number of limitations may deserve comment. Firstly, low
dose aspirin administered to patients with coronary aneur-
ysms may potentially affect serum hs-CRP concentrations.
However, the findings of previous studies of adults with
coronary artery disease and healthy adults are controver-
sial.28–30 Nonetheless, in the positive studies reported so
far,28 29 the effect of low dose aspirin is lowering of serum hs-
CRP concentrations. Thus, in our group I patients, if aspirin
were to have any influence on their serum hs-CRP concen-
trations, the chance of detecting a significant difference
between groups would be minimised rather than exagger-
ated. Secondly, it may be argued that, in the strictest sense,
group I comprised two subsets of patients, as defined by the
persistence or regression of coronary artery aneurysm.
However, the similar morphological and functional coronary
artery abnormalities as reported previously4 suggest that
these patients share similar features of arterial dysfunction. It
is therefore justified to combine the two subsets into a single
group for analysis. Indeed, the hs-CRP concentrations were
similar between the two subgroups. Thirdly, 37% (26 of 71) of
our patients with a history of Kawasaki disease had
persistent coronary aneurysms, a proportion much higher
than that expected after administration of intravenous
immunoglobulin. This is likely to be related to tertiary
referral bias. Nonetheless, this provides an opportunity to
further stratify the patients for comparison of differences in
hs-CRP concentrations and arterial stiffness in different
subgroups.
In summary, our findings support the possibility of
ongoing low grade inflammation late after the acute phase
of Kawasaki disease among patients with coronary aneur-
ysms. Furthermore, this low grade inflammation may play a
part in late systemic artery dysfunction. Suppression of this
chronic inflammatory process may be a new target for
intervention, which may perhaps improve arterial function in
the long term.
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Homozygous familial hyperlipidaemia presenting as severe aortic stenosis and unstable angina
A
51 year old man with a known history of homozygous
familial hyperlipidaemia on regular plasmapheresis,
presented with unstable angina. Examination of the
precordium revealed a harsh ejection systolic murmur grade
4/6 over the aortic area with radiation to the neck. An ECG
showed Q waves over the inferior leads, and sinus rhythm
with left ventricular strain pattern. A coronary angiogram
showed chronic total occlusion of the right coronary artery
and minor disease over the left coronary vessels. Fluoroscopy
showed dense calcification affecting the aortic valves and
proximal portion of the ascending aorta. Transoesophageal
echocardiography demonstrated severely calcified, immobile
aortic valve trileaflets with valve area by planimetry of
,0.8 cm2. A contrast enhanced multislice computed tomo-
graphic (CT) scan was performed to assess the extent of
calcification of the aorta before referral for surgery (panels
A–C: sagittal CT and corresponding three dimensional
reconstruction images).
H H Ho
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Sagittal view of the aorta—note calcified
atherosclerotic plaques extending from the
aortic root upwards in the ascending thoracic
aorta, arch and descending aorta, with plaques
shown in panels B and C.
Three dimensional reconstruction of image A—
anterior view of the ascending aorta.
Three dimensional reconstruction of image A—
left anterior oblique view of aortic arch and
descending aorta.
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